Samit Hirawat

BMY

Samit Hirawat serves as EVP,Chief Med.Offr.,Drug Dev. at Bristol-Myers Squibb Company (BMY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$402.3K

Total Sells

8 trades

$4.69M

Net Position

Net Seller

$4.29M

Companies Traded

BMY

Active Period

Mar 2021 – Apr 2025

11 total trades

Most Recent

Buy BMY

Apr 25, 2025 · $202.2K

Samit Hirawat's Insider Trading at Bristol-Myers Squibb Company (BMY)

Buys

3 · $402.3K

Sells

8 · $4.69M

Total Shares Bought

7,903

Total Shares Sold

73,642

BMY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Apr 25, 2025↗	Buy	4,250	$47.58	$202.2K
Mar 10, 2025↗	Sell	16,056	$63.11	$1.01M
Feb 19, 2025↗	Buy	1,823	$54.85	$100.0K
Nov 1, 2024↗	Buy	1,830	$54.67	$100.1K
Mar 10, 2024↗	Sell	13,649	$53.79	$734.2K
Jul 1, 2023↗	Sell	4,787	$63.95	$306.1K
Mar 10, 2023↗	Sell	22,395	$65.71	$1.47M
Jul 1, 2022↗	Sell	4,786	$76.84	$367.8K
Mar 10, 2022↗	Sell	5,205	$68.42	$356.1K
Jul 1, 2021↗	Sell	4,786	$66.56	$318.6K
Mar 10, 2021↗	Sell	1,978	$60.93	$120.5K